Robust immune responses to SARS-CoV-2 in a pediatric patient with B-Cell ALL receiving tisagenlecleucelArticle Published on 2022-09-012023-07-08 Journal: Pediatric hematology and oncology [Category] COVID19(2023년), [키워드] CD19 directed therapy chimeric antigen receptor SARS-CoV-2 T-cell Response tisagenlecleucel. [DOI] 10.1080/08880018.2022.2035864